{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 315"}, "official-title": {"#tail": "\n\t", "#text": "To provide for the placement of certain synthetic drugs\n\t\t  on Schedule I under the Controlled Substances Act."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130118", "#text": "January 18, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": "\n\t\t\t introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Mrs. Emerson", "@name-id": "E000172"}, "committee-name": [{"#tail": ", and in addition to the Committee on the\n\t\t\t ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}, {"#tail": ", for a period\n\t\t\t to be subsequently determined by the Speaker, in each case for consideration of\n\t\t\t such provisions as fall within the jurisdiction of the committee\n\t\t\t concerned", "@committee-id": "HJU00", "#text": "Judiciary"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H24EA6B0C056E403FA4CF225B4A168B59", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Synthetic Cathinones Control Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H48D1452207F34C93BD68692D738827CF"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Addition of\n\t\t\t synthetic drugs to Schedule I of the Controlled Substances Act"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall, not later than 60 days after the date of the enactment\n\t\t\t of this Act, issue a final order that schedules the following substances on\n\t\t\t schedule I under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "Notwithstanding any\n\t\t\t other provision of the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ", the\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Controlled Substances Act", "@value": "Controlled Substances Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 801 et seq.", "@value": "usc/21/801/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}, {"#tail": ":", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 202(c) of that Act", "@value": "Controlled Substances Act/s:202/ss:c"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 812(c)", "@value": "usc/21/812/c"}], "@entity-type": "law-citation", "#text": "\n            "}], "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "3,4-methylenedioxymethcathinone\n\t\t\t (meth\u00adyl\u00adone)."}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H6D2ED50B6BC44E79A062DF5D06B1CAA8", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Naphthylpyrovalerone\n\t\t\t (naphyrone)."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H9939D31E245945F8980B7E56031FD071", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "4-fluoromethcathinone\n\t\t\t (flephedrone)."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H5E73FE82D8EC4F2BB0756D8B169FB6A6", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "4-methoxymethcathinone\n\t\t\t (methedrone; Bk\u2013PMMA)."}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "HF3BD93C29BA74C709CD84197CB52A557", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Ethcathinone\n\t\t\t (N-ethylcathinone)."}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "HB743709D222245A99223C6419E0FDCDD", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "3,4-methylenedioxyethcathinone\n\t\t\t (ethylone)."}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "H0AB304350A8846929035E9E618260BEC", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Beta-keto-N-methyl-3,4-benzo\u00addi\u00adoxy\u00adoly\u00adbu\u00adtan\u00adamine\n\t\t\t (butylone)."}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "H1944B39FD5464F49AB15CE94363E28E0", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "N,N-dimethylcathinone\n\t\t\t (metamfepramone)."}, "enum": {"#tail": "\n          ", "#text": "(8)"}, "@id": "HAB5CE302178240D3A91C409FD68ABEF4", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Alpha-pyrrolidinopropiophenone\n\t\t\t (alpha-PPP)."}, "enum": {"#tail": "\n          ", "#text": "(9)"}, "@id": "H33A40F2C87EB4C29ADF800FE8385983A", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "4-methoxy-alphapyrrolidinopropiophenone\n\t\t\t (MOPPP)."}, "enum": {"#tail": "\n          ", "#text": "(10)"}, "@id": "H13E296052ECC4CF6B6B4DD424A53FF60", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "3,4-meth\u00adyl\u00adene\u00addi\u00adoxy\u00adalpha\u00adpyrrol\u00adidino\u00adpro\u00adpio\u00adphe\u00adnone\n\t\t\t (MDPPP)."}, "enum": {"#tail": "\n          ", "#text": "(11)"}, "@id": "H462EF5D208C4435E95DB4ADC7FFECFD9", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Alpha-pyrrolidinovalerophenone\n\t\t\t (alpha-PVP)."}, "enum": {"#tail": "\n          ", "#text": "(12)"}, "@id": "HBD3BE3B4271640B1ADBC5F0891C78CD6", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine\n\t\t\t (MDAI)."}, "enum": {"#tail": "\n          ", "#text": "(13)"}, "@id": "H253042C7A50F4A998516A62791CFAF6E", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "3-fluoromethcathinone."}, "enum": {"#tail": "\n          ", "#text": "(14)"}, "@id": "H1727BA5E257A4A9C922E79797990D2AA", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "4\u2032-methyl-\u03b1-pyrrolidinobutiophenone\n\t\t\t (MPBP)."}, "enum": {"#tail": "\n          ", "#text": "(15)"}, "@id": "H04BFECC308BD43EFA5140B80F47979B5", "#text": "\n          "}], "#text": "\n        ", "@id": "HB3BA0DD3253248A78CF45F6CED0079EF"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Subsection (c) of section 202 of the\n\t\t\t Controlled Substances Act", "@value": "Controlled Substances Act/s:202/ss:c"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 802", "@value": "usc/21/802"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Conforming\n\t\t\t amendment To remove deadwood"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "Schedules I, II, III, IV, and V shall\n\t\t\t\tconsist of the drugs and other substances (by whatever official name, common or\n\t\t\t\tusual name, chemical name, or brand name designated) that are set forth in the\n\t\t\t\trespective schedules in part 1308 of title 21, Code of Federal Regulations, as\n\t\t\t\tthey may be amended from time to time, or in any successor\n\t\t\t\tregulation.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Cross reference\n\t\t\t\tto Schedules of Controlled Substances"}, "#text": "\n            ", "@id": "H6D686D9DB1F8486B8E095E91A79B71FC"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HDB9F38D632C341D78ACC48B5E41ADC04"}, "#text": "\n        ", "@id": "H4638A5FC4DEC47369187737EC4528195"}], "#text": "\n      ", "@id": "H13644DE0FF5C4766860A6B2F57A41DAA"}], "#text": "\n\t\t", "@id": "H03AA638B9DA54FCB92F8AA896EC26D45"}}}